Advertisement

Topics

Companies Related to "Visilizumab for the Prevention of Graft-versus-Host Disease After Allogeneic Hematopoietic Cell Transplantation" [Most Relevant Company Matches] - Page: 5 RSS

13:30 EDT 18th March 2019 | BioPortfolio

Here are the most relevant search results for "Visilizumab for the Prevention of Graft-versus-Host Disease After Allogeneic Hematopoietic Cell Transplantation" found in our extensive corporate database of over 50,000 company records.

Showing "Visilizumab Prevention Graft versus Host Disease After Allogeneic" Companies 101–125 of 3,300+

Probably Relevant

Oxford Biomedical Research, Inc.

Oxford Biomedical Research (OBR) develops, manufactures and markets assay kits, recombinant proteins and antibodies for biomedical research and drug discovery. The company’s primary focus is on the identification and assay of biomarkers for oxidative stress and chronic inflammation, two major risk factors for multiple diseases. OBR is employing proprietary technology to develop tissue and diseas...


National Kidney Foundation Singapore

The World Kidney Fund was established as an international fund by the National Kidney Foundation Singapore to help kidney patients in developing countries who have little or no access to renal healthcare facilities. Through this fund, training programmes are developed to empower non-profit kidney organisations to establish sustainable life-saving kidney healthcare programmes. The World Kidney Fun...

BioSyn Incorporated

Biosyn is a specialty pharmaceutical company developing novel, topical-delivery drugs for the treatment and prevention of infectious disease in areas of critical medical need. The Company has built a robust pipeline based upon four technology platforms addressing major anti-infective markets where the use of topical delivery offers significant advantages over systemic therapy. In the area of HIV...


Lions Ear and Hearing Clinic

Hearing loss and ear disease amongst Australians is almost at an epidemic stage.The Australian Bureau of Statistics' 2001 National Health Survey revealed nearly 2.5 million people were affected by hearing loss, with tens of thousands of children and adults currently suffering from ear disease.The Lions Ear and Hearing Institute is dedicated to reducing these rising figures by researching into the ...

Heat Biologics, Inc.

Heat Biologics (www.heatbio.com) (“Heat”) is a clinical-stage company immunotherapy company focused on developing its novel off-the-shelf “ImPACT” (Immune Pan-Antigen Cytotoxic Therapy) therapeutic vaccines to combat a wide range of cancers and other diseases. Heat’s ImPACT Therapy effectively reprograms tumor cells to “pump o...

Canadian Centre for Pollution Prevention

The Canadian Centre for Pollution Prevention is a non-government, environmental organization that encourages actions that avoid or minimize the creation of pollutants—actions that foster a healthier environment and a sustainable society. C2P2’s core business is the transfer of P2 information and serves as a catalyst for behavioural change. C2P2 enriches the knowledge of others so that they can...

Aviir, Inc.

Founded in 2005 by cardiologists and researchers from the Stanford University School of Medicine , Aviir is focused on the discovery, development and commercialization of innovative diagnostic and predictive cardiovascular tests, employing state of the art laboratory diagnostic methods. Aviir’s CLIA laboratory in Irvine, CA offers a range of tests for...

Gemmus Pharma Inc.

Gemmus is a privately held biotechnology company focused on the development of innovative pharmaceutical products for the treatment of infectious diseases by modulating the host response to the disease. Gemmus was founded in 2007 to develop EP2 and EP4 agonists for the treatment for the treatment of influenza and in-licensed technology from a major pharmac...

Biosynexus

Biosynexus Incorporated is a biopharmaceutical company that is commercializing a portfolio of products for the prevention and treatment of infectious diseases. The company has focused its initial efforts on developing products for the prevention and treatment of hospital acquired – nosocomial – staphylococcal infections

Biomonitoring Info

What: An expert specializing in communications to the general public on the scientific techniques for assessing and interpreting the significance of human exposure to natural and synthetic chemicals is available to provide comment and analysis on the upcoming report on biomonitoring by the Centers for Disease Control and Prevention (CDC). For information o...

Implicit Bioscience Ltd

Implicit Bioscience Ltd is a public unlisted Australian biopharmaceutical company based in Brisbane (Australia) and Seattle, WA that develops drugs which modulate the host immune response to disease. Its business model is to mitigate both product risk and capital risk, through the in-licensing and development of clinical stage programs that have known safety profiles in man, and present opportunit...

CardioCell LLC

Founded in San Diego, Calif., in 2013, CardioCell LLC is a global biotechnology company that explores therapeutic applications of unique, patented, ischemia-tolerant mesenchymal stem cells (itMSCs) manufactured under cGMP conditions. CardioCell is a subsidiary of Stemedica Cell Technologies Inc., a global biotechnology company that manufactures adult allog...

Crohns & Colitis Foundation of America

Crohn's disease, a chronic inflammatory disease of the gastrointestinal tract, affects approximately 500,000 Americans, including approximately 100,000 pediatric patients. The cause of Crohn's disease is not known, but the disease is associated with an abnormality of the immune system that could be triggered by viral or bacterial infections, a genetic predisposition or diet. Symptoms of Crohn's ...

Ouroboros Medical, Inc.

Ouroboros Medical, Inc. is an early stage, medical device company with corporate headquarters in Pleasanton, California, and operations in both California and New York. Ouroboros is developing minimally invasive spine systems for degenerated disc disease. Ouroboros’s platform device – the OSS - is a minimally invasive device that circumferentially ...

Chimeric Therapies Incorporated

Chimeric Therapirs Incorporated is committed to developing bone marrow graft engineering to expand the use of safe and effective cellular grafts tailored to treat and cure diseases.

Cequent Pharmaceuticals, Inc.

An early-stage biopharmaceutical company, Cequent is pioneering the development of novel therapeutics to prevent and treat a wide range of human disorders -- from inflammatory disease to cancer -- based on the company's proprietary technology, TransKingdom RNA interference (tkRNAi(TM)). Cequent's first products, now entering clinical development, are orally administered drug candidates targeting c...

Vedanta Biosciences

Vedanta Biosciences, a privately held company, was co-founded by PureTech Ventures and a group of world renowned experts in immunology and microbiology. Vedanta Biosciences' mission is to develop a novel class of therapies that modulate pathways of interaction between the human microbiome and the host immune system. The technology developed by Dr. Honda and colleagues at the University of Tokyo fo...

Synergy Wound Technology

Synergy Wound Technology is a technology-driven product development company that specializes in wound management, prevention, early evaluation of vascular disease for compression, and measurement of effectiveness after initiation of compression. For more information, visit www.synergywoundtech.com

Dental Optimizer

Dental Optimizer™ is an online tool that helps you helps you understand what you can do to prevent dental disease, what treatments are the most effective and what your care might cost you. You can use this tool to learn how prevention benefits you - whether it means fewer oral health issues, less time in the dentist’s chair, or lower out-of pocket costs...

Tayside Flow Technologies Limited

TFT was formed in October 1998 as a spinout company from Tayside University Hospitals NHS TrustTayside Flow Technologies Ltd (TFT) is focused on the research, development and early stage commercialisation of vascular devices based on a new understanding of blood flow dynamics - Spiral Laminar Flow (SLF™ technology). The cardiovascular market is estimated at £11bn ($18bn equivalent) worldwide wi...

Batu Biologics

Founded in 2013, Batu Biologics is a preclinical biopharmaceutical company focusing on developing and commercializing allogeneic cell therapies in the area of immune modulation. The company’s products are centered around the idea of creating or breaking immune tolerance. The company is currently in the preclinical stages of drug development for its tw...

Schülke&Mayr GmbH

Schülke & Mayr is an international leader in the areas of hygiene and prevention of infection, and also in Microbiological Quality Management (MQM) and chemical technical preservation. We supply disinfectants, antiseptics, preservatives, biocides, medical skin care products, an active substance for deodorants, and system cleaners. Thus we offer comprehensive protection against harmful organisms ...

vTv Therapeutics, Inc.

vTv Therapeutics Inc. is a clinical-stage biopharmaceutical company engaged in the discovery and development of orally administered small molecule drug candidates to fill significant unmet medical needs. vTv Therapeutics has a pipeline of clinical drug candidates for the treatment of Alzheimer’s disease, diabetes, inflammatory disorders and the pre...

Cognitive Clinical Trials

Cognitive Clinical Trials (CCT) is a company offering an innovative approach to conducting clinical research for the prevention and treatment of Alzheimer’s Disease. CCT embeds research facilities in senior living communities, which simplifies the process for patients and provides sponsors with high quality data. For more information, visit www.cctresearch.c...

AccessDNA, Inc.

AccessDNA is the leading online consumer resource for genetics. The company combines high-quality content about genetics with access to, and evaluation of, relevant testing, counseling, and support services. By providing valuable insight into the genetics of disease, AccessDNA helps people better understand their treatment, management and prevention option...


More From BioPortfolio on "Visilizumab for the Prevention of Graft-versus-Host Disease After Allogeneic Hematopoietic Cell Transplantation"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks